18:52:11 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



SEC target Georgiou appeals fraud conviction, again

2015-02-06 11:27 ET - Street Wire

Also Street Wire (U-*SEC) U S Securities and Exchange Commission
Also Street Wire (U-AVCE) Avicena Group Inc
Also Street Wire (U-HYHY) Hydrogen Hybrid Technologies Inc
Also Street Wire (U-NOET) Northern Ethanol Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

George Georgiou, the former Toronto broker serving 25 years in jail for fraud in the United States, is trying once again to have the appeal court overturn his conviction. He has requested a hearing before all of the judges of the U.S. Court of Appeals for the Third Circuit. His lawyer plans to argue, perhaps more forcefully than in a prior appeal, that prosecutors failed to properly disclose addiction and mental health issues with a key witness.

The request comes as Mr. Georgiou, 45, is approaching the fifth anniversary of his conviction. During his 13-day trial in February, 2010, prosecutors claimed that he ran an international stock fraud ring from 2004 to 2008 that caused $55.8-million in investor losses. (All figures are in U.S. dollars.) Among other things he manipulated four pink sheets listings, tried to bribe brokers and caused the demise of a Bahamian brokerage, the government said.

Mr. Georgiou first appealed his conviction in 2011, complaining that prosecutors knowingly suppressed problems with a key witness, a man named Kevin Waltzer. Among other things, he said that prosecutors hid the full extent of Mr. Waltzer's alcohol and cocaine addictions. They also did not fully disclose mental health issues, which included diagnoses of anxiety and depression, Mr. Georgiou claimed. Cross-examination of Mr. Waltzer before the jury "would have been absolutely devastating" had the defence known about his conditions, the appeal stated.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2024 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.


Comments for this item are closed